XT
LENZ

XTX Topco’s LENZ Therapeutics LENZ Stock Holding History

XTX Topco’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$742K Sell
130,625
-90,412
-41% -$729K 0.01% 2075
2026
Q1 		$2.02M Buy
221,037
+135,255
+158% +$1.9M 0.04% 829
2025
Q4 		$1.37M Buy
+85,782
New +$2.5M 0.04% 798
2024
Q1 		– Sell
-2,782
Closed -$51K – 2411
2023
Q4 		$51K Buy
2,782
+725
+35% +$12K 0.01% 1228
2023
Q3 		$35.7K Buy
+2,057
New +$35.8K 0.01% 1316
2022
Q3 		– Sell
-1,510
Closed -$29K – 1434
2022
Q2 		$29K Buy
+1,510
New +$33.7K 0.01% 794

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

XTX Topco's LENZ Position: Q2 2026 in Review

XTX Topco reduced its LENZ Therapeutics (LENZ) stake by 41% in Q2 2026, selling an estimated $729K and leaving 130,625 shares worth $742K. The position accounts for 0.01% of the portfolio, ranked #2075.

XTX Topco first reported a position in LENZ in Q2 2022 and has held it in 6 quarters since. The position peaked at $2.02M in Q1 2026. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • XTX Topco held 130,625 shares of LENZ Therapeutics worth $742K as of Q2 2026.
  • XTX Topco sold 90,412 LENZ Therapeutics shares in Q2 2026, an estimated $729K.
  • LENZ Therapeutics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2075 holding.
  • XTX Topco first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • XTX Topco's LENZ Therapeutics position peaked at $2.02M in Q1 2026.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.